一例在使用血小板生成素受体激动剂肽--罗米司亭治疗期间发生的急性支架血栓形成。
A case of acute stent thrombosis during treatment with the thrombopoietin receptor agonist peptide--romiplostim.
机构信息
Department of Cardiology, The Northern Hospital, 185 Cooper Street, Epping, VIC 3076, Australia.
出版信息
Heart Lung Circ. 2012 Mar;21(3):182-4. doi: 10.1016/j.hlc.2011.09.001. Epub 2011 Oct 2.
Romiplostim is a thrombopoietin receptor agonist that increases platelet counts and restores platelet function in patients with chronic immune thrombocytopenia (ITP). Increase in platelet count and platelet activation has been associated with increased thromboembolic risk. The present case report describes an interesting case of acute stent thrombosis in a patient with chronic immune thrombocytopenic purpura (ITP) being treated with romiplostim.
罗米司亭是一种促血小板生成素受体激动剂，可增加血小板计数并恢复慢性免疫性血小板减少症 (ITP) 患者的血小板功能。血小板计数和血小板活化的增加与血栓栓塞风险的增加有关。本病例报告描述了一例使用罗米司亭治疗的慢性免疫性血小板减少性紫癜 (ITP) 患者发生急性支架血栓形成的有趣病例。
Zotero 插件